Li Lu

机构：East China University of Science and Technology, Guangdong Medical College, Sichuan University, Universal College, Shanghai Chest Hospital, Zhengzhou University, West China Hospital of Sichuan University, Second Affiliated Hospital of Xi'an Jiaotong University, Henan Provincial People's Hospital, Beijing Hospital of Traditional Chinese Medicine, Jiangsu Province Hospital, Beijing Haidian Hospital, Henan Provincial Center for Disease Control and Prevention, Zhejiang University of Technology, Nanjing Medical University, Chongqing Medical University, Air Force Medical University · ORCID：0000-0002-7132-5035

发表论文 147 篇 · 总被引 5065 次 · h-index 33

代表论文

• Interferon-γ-stimulated antigen-presenting cancer-associated fibroblasts hinder neoadjuvant chemoimmunotherapy efficacy in lung cancer (2025 · Cell Reports Medicine · 被引 24)
• Breaking the Tumor Chronic Inflammation Balance with a Programmable Release and Multi‐Stimulation Engineering Scaffold for Potent Immunotherapy (2024 · Advanced Science · 被引 18)
• Protective effects and mechanisms of quercetin in animal models of hyperuricemia: A systematic review and meta-analysis (2025 · Pharmacological Research · 被引 17)
• Efficacy and safety of preventing catheter-associated urinary tract infection by inhibiting catheter bacterial biofilm formation: a multicenter randomized controlled trial (2024 · Antimicrobial Resistance and Infection Control · 被引 15)
• Chenodeoxycholic Acid Improves Embryo Implantation and Metabolic Health through Modulating Gut Microbiota–Host Metabolites Interaction during Early Pregnancy (2023 · Antioxidants · 被引 15)
• Real-world incidence and risk factors of pneumonitis in chemoradiation plus immune checkpoint inhibitors compared with chemoradiation alone in lung cancer: a retrospective cohort study (2024 · Translational Lung Cancer Research · 被引 7)